Does albuterol raise heart rate
Pro Research Analysisby 
Searched over 200M research papers
The Impact of Albuterol on Heart Rate: A Comprehensive Review
Introduction to Albuterol and Heart Rate
Albuterol, a commonly used bronchodilator, is often prescribed to manage conditions such as asthma and chronic obstructive pulmonary disease (COPD). While its primary function is to relax the muscles in the airways and increase airflow to the lungs, there is ongoing debate about its potential effects on heart rate. This article synthesizes findings from multiple studies to provide a clear understanding of how albuterol impacts heart rate.
Albuterol and Heart Rate in Intensive Care Patients
Research has shown that the effects of albuterol on heart rate can vary depending on the patient's baseline heart condition. In a study involving intensive care patients, those without baseline tachycardia experienced a significant increase in heart rate after receiving nebulized albuterol, with a mean increase of 4.4 beats per minute (6.7%)1. Conversely, patients with baseline tachycardia did not show a significant increase in heart rate, indicating that the impact of albuterol may be more pronounced in patients with normal baseline heart rates1.
High-Dose Albuterol and Cardiac Stimulation
High-dose albuterol treatments have been associated with more noticeable increases in heart rate. In a study involving adult asthmatics treated with high-dose continuously aerosolized albuterol, a mean heart rate increase of 16.3% was observed2. This study also reported a case of supraventricular tachycardia, which subsided upon discontinuation of albuterol, highlighting the potential for significant cardiac stimulation at higher doses2.
Albuterol in Non-Asthmatic Athletes
The effects of albuterol on heart rate are not limited to asthmatic patients. In a study involving non-asthmatic competitive cyclists, inhaled albuterol led to a significant increase in heart rate during submaximal exercise workloads3. Specifically, heart rates were significantly higher at 200, 225, and 250 watts compared to a placebo, indicating that even in healthy individuals, albuterol can elevate heart rate during physical exertion3.
Dose-Related Cardiac Effects
The relationship between albuterol dosage and heart rate has been further explored in patients with severe chronic airflow limitation. Higher doses of inhaled albuterol were associated with a dose-related increase in heart rate, tremor amplitude, and supraventricular ectopic beats4. This suggests that while higher doses may provide greater bronchodilation, they also carry an increased risk of cardiac side effects4.
Albuterol in Pediatric Patients
In pediatric patients, the cardiac effects of albuterol appear to be minimal. A study involving asthmatic children treated with repeated doses of albuterol aerosol found no significant changes in heart rate or development of arrhythmias6. This indicates a substantial margin of safety for albuterol use in children, even with frequent dosing6.
Comparison with Other Bronchodilators
When compared to other bronchodilators like epinephrine, albuterol's impact on heart rate is similar. Both subcutaneous albuterol and epinephrine caused comparable increases in heart rate and decreases in serum potassium levels in adult asthmatic subjects10. This suggests that while albuterol is effective in improving pulmonary function, it shares similar cardiac side effects with other bronchodilators10.
Conclusion
In summary, albuterol can raise heart rate, particularly at higher doses and in patients without baseline tachycardia. While its use is generally safe, especially in pediatric patients, caution is advised in high-dose treatments due to the potential for significant cardiac stimulation. Understanding these effects is crucial for optimizing the therapeutic use of albuterol while minimizing adverse cardiac outcomes.
Sources and full results
Most relevant research papers on this topic
Changes in heart rate associated with nebulized racemic albuterol and levalbuterol in intensive care patients.
Nebulized albuterol and levalbuterol both cause similar short-term increases in heart rate in intensive care patients with or without baseline tachycardia.
RCTHigh serum albuterol levels and tachycardia in adult asthmatics treated with high-dose continuously aerosolized albuterol.
High-dose continuously aerosolized albuterol treatment in adult asthmatics can result in elevated serum albuterol levels and potential cardiac stimulation, despite spirometric improvement.
Non-RCTEffects of Acute Inhalation of Albuterol on Submaximal and Maximal V̇O2 and Blood Lactate
Inhaled albuterol at twice the recommended dosage does not improve endurance performance or pulmonary function in athletes who are not asthmatic.
RCTHigh-dose inhaled albuterol in severe chronic airflow limitation.
Higher doses of inhaled albuterol significantly increase airflow in patients with severe chronic airflow limitation, but may increase side effects and require a dose balancing study.
RCT
Highly CitedEfficacy of albuterol in the management of bronchiolitis.
Albuterol is as effective as oral placebo in managing bronchiolitis in infants, with past studies not considering change in infant state and using a truly inactive placebo group.
RCTHighly CitedLack of Cardiac Effect from Repeated Doses of Albuterol Aerosol
Repeated doses of albuterol aerosol in asthmatic children show a substantial margin of safety, with no cardiac effect and infrequent side effects.
RCTEffects of acute inhalation of the bronchodilator, albuterol, on power output.
Acute inhalation of albuterol significantly increases short-term power output without affecting respiratory smooth muscle or cardiac response.
RCTHighly CitedContinuous versus intermittent albuterol nebulization in the treatment of acute asthma.
Both intermittent and continuous albuterol nebulization are safe for treating acute asthma, with continuous nebulization showing a higher rate of percent predicted FEV1 increase.
RCTHighly CitedEfficacy of parenteral albuterol in the treatment of asthma. Comparison of its metabolic side effects with subcutaneous epinephrine.
Parenteral albuterol effectively improves asthma symptoms, with similar effects on serum potassium levels as subcutaneous epinephrine, potentially impacting clinical outcomes.
RCT